Diagnostic and prognostic information provided by a high sensitivity assay for cardiac troponin T

Journal of Medical Biochemistry

Volumn 29, Issue 4, 2010, Pages 274-281

  Jarausch, Jochen ^a  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

acute myocardial infarction; cardiac troponin; high sensitivity cardiac troponin assay

Indexed keywords

ANTICOAGULANT AGENT; TROPONIN T;

DIAGNOSTIC PROCEDURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MEDICAL INFORMATION; REVASCULARIZATION; REVIEW; SENSITIVITY ANALYSIS;

EID: 77958087315     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-010-0041-8     Document Type: Review

References (56)

1. Myocardial infarction redefined: a consensus docu ment of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36: 959-69;
2. Eur Heart J 2000; 21: 1502-13.
3. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for theRedefinition of Myocardial Infarction, Universal definition of myocardial infarction. J Am Coll Cardiol 50 (2007) 2173-2195;
4. Circulation 2007; 116: 2634-53.
5. Antman EM, Tanasijević MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342-9.
6. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 1996; 335: 1333-41.
7. Morrow DA, Cannon C P, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001; 286: 2405-12.
8. James S, Armstrong P, Califf R, et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 2003; 115: 178-84.
9. Wallentin L, Lagerqvist B, Husted S, Kontny F, Ståhle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet 2000; 356: 9-16.
10. Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999; 340: 1623-9.
11. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet 1999; 354: 1757-62.
12. Newby LK, Ohman EM, Christenson RH, Moliterno DJ, Harrington RA, White HD, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: the paragon-B cTnT substudy. Circulation 2001; 103:2891-2896
13. Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol 1997; 29: 43-8.
14. Todd J, Freese B, Lu A, Held D, Morey J, Livingston R, et al. Ultrasensitive flow-based immunoassays using single-molecule counting. Clin Chem 2007; 53: 1990-5.
15. Apple F. A New Season for Cardiac Troponin Assays: It's Time to Keep a Scorecard. Clinl Chem 2009; 55: 1303-6.
16. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year old men. A community-based cohort study. Circulation 2006; 113: 1071-8.
17. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009; 55: 85-92.
18. Gaze CD. Sensitive cardiac troponin assays: Muth and Magic or a practical way forward? Journal of Medical Biochemistry 2010; 29: 269-73.
19. Jaffe A, Apple FS. High-Sensitivity Cardiac Troponin: Hype, Help, and Reality. Clin Chem 2010; 56: 342-4.
20. Giannitsis E, Roth HJ, Leithäuser RM, Scherhag J, Beneke R, Katus HA. New highly sensitive assay used to measure cardiac Troponin T concentration changes during a continuous 216-km marathon. Clin Chem 2009; 55: 590-2.
21. Middleton N, George K, Whyte G, Gaze D, Collinson P, Shave R. Cardiac Troponin T release is stimulated by endurance exercise in healthy humans. JACC 2008; 52: 1813-14.
22. Mingels A, Jacobs LHJ, Kleijnen VW, Laufer EM, Winkens B, Hofstra L, Wodzig WKWH, Van Dieijen-Visser M P. Cardiac troponin T elevations, using highly sensitive assay, in recreational running depend on running distance. Clin Res Cardiol 2010; 99: 385-91.
23. Koller A. Exercise-induced increases in cardiac troponins and prothrombotic markers. Med Sci Sports Exerc 2003; 35: 444-8.
24. Sabatine MS, Morrow DA, De Lemos JA, et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009; 30: 162-9.
25. Wang AYM, Lai KN. Use of Cardiac Biomarkers in End-Stage Renal Disease. J Am Soc Nephrol 2008; 19: 1643-52.
26. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010; 56: 254-61.
27. Beyrau R, Braun S, Cooray R, et al. Multicentre evaluation of a high sensitive Elecsys troponin T assay. Clin Chem Lab Med 2009; 47: S128.
28. Jarausch J, Braun S, Dolci A, et al. Evaluation of a development version of the Elecsys high sensitive troponin T assay. Clin Chem 2008; 54: A91.
29. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac cTnI measured by the high-sensitivity cardiac troponin I Access prototype assay and the impact on the diagnosis of Myocardial Ischemia. J Am Coll Cardiol 2009; 54: 1165-72.
30. Kavsak PA, Wang X, Ko D T, MacRae AR, Jaffe AS. Short-and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009; 55: 1809-15.
31. Mingels A, Jacobs L, Michielsen E, et al. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009; 55: 101-8.
32. Prontera C, Fortunato A, Storti S, et al. Evaluation of analytical performance of the Siemens ADVIA TnI ultra immunoassay. Clin Chem 2007; 53: 1722-3.
33. Wallace TW, Abdullah SM, Drazner MH, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006; 113: 1958-65.
34. Omland T, De Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E, Investigators. PoEwACEIPT. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009; 361: 2538-47.
35. Morrow D, Cannon C, Jesse R, Newby L, Ravkilde J, Storrow A, Wu A, Christenson R. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007; 53: 552-74.
36. Wu AHB, Apple FS, Jaffe AS, Jesse RL, Morrow DA, Newby K, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: use of cardiac cTn and the natriuretic peptides for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007; 53: 2086-96.
37. Wu AH, Lu QA, Todd J, et al. Short-and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009; 55: 52-8.
38. Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM. Use of VITROS Troponin I ES assay for early diagnosis of myocardial infarction and predicting of adverse events: role of following deltas. Clin Chem 2009; 55: 930-7.
39. Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. High sensitivity cardiac cTn T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative cTn results at admission. Clin Chem 2010; 56: 642-50.
40. Casals G, Filella X, Augé JM, Bedini JL. Impact of ultrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction. Am J Pathol 2008; 130: 964-8.
41. Giannitsis E, Katus HA. Current recommendations for interpretation of the highly sensitive troponin T assay for diagnostic purposes in patients with a non-ST-segment-elevation acute coronary syndrome. European Cardiology 2009; 5: 3-6.
42. White HD. Higher sensitivity troponin levels in the community: What do they mean and how will the diagnosis of myocardial infarction be made? Am Heart J 2010; 159: 933-6.
43. Kelley WE, Januzzi JL, Christenson RH. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 2009; 55: 2098-112.
44. Wu AHB. Interpretation of high sensitivity cardiac troponin I results: Reference to biological variability in patients who present to the emergency room with chest pain: Case report series. Clin Chim Acta 2009; 401: 170-4.
45. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Fröhlich M, Sinning CR, Eleftheriadis MS, Wild PS, Schnabel RB, Lubos E, Jachmann N, Genth-Zotz S, Post F, Nicaud V, Tiret L, Lackner KJ, Münzel T F, Blankenberg S. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361: 868-77.
46. Sypniewska G, Sawicki M, Krintus M, Kozinski M, Kubica J. The use of biochip cardiac array technology for early diagnosis of acute coronary syndromes. Journal of Medical Biochemistry 2009; 28: 293-9.
47. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361: 858-67.
48. Wilson SR, Sabatine MS, Braunwald E, et al. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial. Am Heart J 2009; 158: 386-91.
49. Latini R, Masson S, Anand I, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni A, Tognoni G, Cohn J, Investigator V-H. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007; 116: 1242-9.
50. Ooi DS, Isotalo PA, Veinot J P. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clin Chem 2000; 46: 338-44.
51. Apple FS, Sharkey SW, Hoeft P, Skeate R, Voss E, Dahlmeier BA, Preese LM. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: A 1-year outcomes analysis. Am J Kidney Dis 1997; 29: 399-403.
52. Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant 1998; 13: 1709-12.
53. Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, Ohman EM, Mahaffey KW, Newby LK, Califf RM, Simoons ML, Topol EJ, Berger P, Lauer MS. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002; 346: 2047-52.
54. Abbas NA, John RI, Webb MC, Kempson ME, Potter AN, Price C P, Vickery S, Lamb EJ. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem 2005; 51: 2059-66.
55. Jacobs LH, van de Kerkhof J, Mingels AM, Kleijnen VW, van der Sande FM, Wodzig WK, Kooman J P, Van Dieijen-Visser M P. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009; 46: 283-90.
56. McGill D, Talaulikar G, Potter JM, Koerbin G, Hickman PE. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin Chim Acta 2010; 411: 936-9.